No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Humans
-
Lenalidomide / therapeutic use
-
Multiple Myeloma* / drug therapy
Substances
-
daratumumab
-
Antibodies, Monoclonal
-
Lenalidomide